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Given that adolescence poses a high-risk period for diabetes mismanagement, and 
consequently, threats to long-term health status, it is important to examine factors that 
contribute to individual differences in the propensity to exhibit poor management and 
engage in health incompatible behaviors. Importantly, researchers have identified 
personality constructs related to disinhibition, including impulsivity, sensation seeking, 
and risk-taking propensity, to be prospectively linked to engagement in real-world risk 
behaviors such as use of alcohol, nicotine, illegal drugs, and risky sexual behavior 
(Lejuez et al., 2002, 2003). However, this relationship has yet to be explored in 
adolescents with diabetes. Thus, the purpose of the current study was to examine whether 
disinhibition was related to metabolic control, and the extent to which self-management 
behavior and drug/alcohol use mediated this potential relationship. The sample consisted 
of 43 subjects with Type 1 diabetes aged 13-18 years who were recruited from diabetes 
clinics at Children’s National Medical Center. Teens were assessed with self-report and 
behavioral measures of risk-taking and participated in an interview regarding self-
management behaviors. Substance use and diabetes knowledge were measured by self 
report, and the glycosylated hemoglobin (HbA1c) test was used as a proxy for metabolic 
control. Results of partial correlational analyses indicated that disinhibition was not 
  
  
directly related to behavioral adherence, engagement in health incompatible behaviors, or 
glycemic control after controlling for race, gender, and insulin regimen type. Rather, 
results of regressional analyses suggested that sample characteristics, particularly race 
and insulin regimen, are the key variables in assessing overall management in 
adolescence. Results may have important implications for the prevention and treatment of 
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Chapter 1: Introduction 
 
Type 1 Diabetes  
Type 1 diabetes (insulin dependent diabetes mellitus [IDDM]; juvenile diabetes) 
is a chronic autoimmune disease characterized by the destruction of insulin-producing 
beta cells in the pancreas. Without the hormone insulin, the body loses its ability to 
metabolize carbohydrates, thereby compromising many aspects of growth, wound 
healing, and brain function (Peterson, Reach, & Grabe, 2003; Wysocki, Greco, & 
Buckloh, 2003). Whereas Type 1 diabetes results from insulin deficiency, Type 2 
diabetes results from insulin resistance (an impaired cellular uptake of insulin) and may 
be managed with diet and exercise alone, or with oral medications that enhance body’s 
use of insulin (Wysocki et al., 2003). In contrast, all children with Type 1 diabetes rely on 
daily insulin replacement to survive. 
Although the incidence of Type 2 diabetes has been increasing in recent years, 
Type 1 diabetes is the most prevalent type diagnosed in childhood. In the U.S., 
approximately 1 in 600 school-aged children are afflicted with Type 1 diabetes, making it 
one of the most common chronic illnesses diagnosed in children (Wysocki et al., 2003). 
Genetic predispositions have some relationship to the etiology of Type 1 diabetes; 
however, unknown environmental factors appear to play a role as well (Johnson, 1998). 
The onset of Type 1 diabetes typically occurs in middle childhood, and symptoms may 
include fatigue, thirst, frequent urination, and weight loss (Peterson et al., 2003). 
Treatment of this condition involves a daily regimen of monitoring food intake, blood 
glucose (BG) levels, and activity, in addition to insulin replacement via subcutaneous 
injections or use of an insulin pump, which delivers insulin through a catheter (Peterson 
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et al., 2003). Because there is no cure for diabetes, the condition requires compliance 
with complex daily regimens over the course of the lifespan in order to regulate glucose 
metabolism. 
Although insulin replacement therapy allows children with diabetes to live 
relatively normal lives, it only approximates normal pancreatic function. Therefore, blood 
glucose levels regularly fluctuate outside of a normal range even with proper 
management. There are two conditions that result when large deviations in blood glucose 
levels occur. The first, hypoglycemia, is characterized by a low BG level (typically 
defined as below 80 mg/dl; Chase, 2002). This condition can occur if the dose of insulin 
provided is too high, when meals or snacks are missed, or with extra exercise. Symptoms 
often include sweating, shaking or shakiness. Severe hypoglycemia can lead to 
unconsciousness and seizures, and can be associated with permanent brain damage 
(Rovet, 2000).  
The second condition that results from deviations in blood glucose levels, 
hyperglycemia, occurs when BG levels are too high (typically defined as above 200 
mg/dl; Chase, 2002). Hyperglycemia can occur when insulin doses are missed, or an 
insufficient dose is provided. Without adequate amounts of insulin, the body is unable to 
use carbohydrates for energy, and the body begins to starve (Peterson et al., 2003). The 
effects of chronic hyperglycemia are cumulative and thus, are rarely seen in young 
children. However, they appear to have their beginnings in puberty (Kostraba, 1989). 
Although both hypo and hyperglycemia occur even with well-controlled diabetes, chronic 
and large deviations from the normal range can be a function of poor management and 
can lead to serious conditions. For example, chronic hyperglycemia is associated with 
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vascular disturbances, including heart disease, retinopathy, nephropathy, and neuropathy. 
Further, prolonged severe hyperglycemia can lead to a serious condition called diabetic 
ketoacidosis (DKA), which can cause permanent neurological dysfunction and has a 1-
2% mortality rate (Kitabchi & Wall, 1995). 
Medical Management  
 Good diabetes management is essential to long-term health. The results of a 
landmark clinical trial has shown that good metabolic control and adherence to regimen 
components can delay, decrease, or prevent complications associated with diabetes 
(Diabetes Control and Complications Trial [DCCT], 1993; 1994). Insulin replacement 
therapy is the most important daily behavior involved in overall management of diabetes. 
Typically, insulin administration involves injections two or more times a day, with the 
goal of maintaining BG levels within a normal range. In children 12 years and older, it is 
generally recommended that blood sugar levels be kept within a range of 70-150 mg/dl 
(Chase, 2002). Therefore, an important aspect of management involves daily monitoring 
of BG levels (generally recommended at least 4 times a day) so that appropriate steps can 
be taken to manage hypo or hyperglycemia.  The practice of monitoring glucose levels 
relies on a finger prick, used with a needle or specialized equipment. Blood is then placed 
into a computerized meter that reports current blood glucose levels (Peterson et al., 
2003). See Appendix A for additional detail regarding medical management of Type 1 
diabetes. 
 As previously noted, many factors other than insulin can impact metabolic 
function. For example, certain lifestyle practices such as diet and exercise can impact BG 
levels. Therefore, as part of overall management, physicians often will recommend that 
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individuals meet with a nutritionist to work out a plan that involves attention to timing of 
meals and number of carbohydrates per meal. In addition, it is important that individuals 
with diabetes engage in regular exercise as it helps lower BG and improve insulin action 
(Johnson, 1998). Although insulin replacement, diet, and exercise are aspects of 
managing diabetes that are within an individual’s control, there are other factors that can 
impact metabolic function that occur largely outside one’s control. For example, illness, 
stress, hormones, and genetic factors all contribute to BG variability (Johnson, 1998). See 
Appendix B for additional detail regarding self-management and behavioral issues related 
to metabolic control. In sum, achieving an overall pattern of good metabolic control 
involves daily behavioral adherence to multifaceted regimens and lifestyle decisions.  
To take into account the multidimensional nature of diabetes management 
behaviors, the term diabetes self-management (DSM) has been used to encompass 
behaviors aimed at the “establishment, maintenance, and monitoring of diabetic control, 
as well as the prevention or correction of deviations from targeted blood glucose levels 
(Harris et al., 2001, pg 1301).” This term emphasizes the amount, accuracy, and 
regularity of behaviors rather than just the degree to which behavior coincides with ideal 
medical advice (typically referred to as adherence or compliance). Extant research 
suggests that adherence with various regimen components is uncorrelated and 
differentially stable over time (Johnson, 1992, 1994). Therefore, self-management better 
represents the set of behaviors related to ongoing management of diabetes.  
 Issues related to DSM represent the leading reason that individuals with diabetes 
are referred to health psychologists (Ruggiero & Javorsky, 1999). Although specific rates 
of engagement in DSM are unknown, longitudinal studies indicate that management is 
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best at the time of diagnosis and deteriorates after that time (Jacobson et al., 1990). 
Diabetes management problems and poor metabolic control have been reported to be 
greater in adolescence than during younger and older age periods and most research 
shows reduced treatment compliance as children develop and reach adolescence (e.g., 
Hamilton & Daneman, 2002; Jacobson et al., 1990; Kovacs, Goldston, Obrosky, & 
Iyengar, 1992). This lack of sufficient attention to diabetes management is particularly 
problematic because this developmental period is accompanied by physiological changes 
(i.e. growth hormones) that may adversely impact metabolism, above and beyond the 
effects of poor self-management. In addition, adolescents are more likely than younger 
children and adults to engage in other behaviors that are incompatible with good diabetes 
management, such as drug, alcohol, and tobacco use (Rowe & Linver, 1996; United 
States Department of Health and Human Services, [USDHHS], 1994). As will be 
discussed subsequently, adolescents with diabetes are much more vulnerable to the 
effects of substance use, and use of tobacco, alcohol and illicit substances can cause 
serious short and long-term complications. Therefore, although substance use is not 
directly related, nor included, in measures of self-management, it is clearly an important 
aspect of diabetes self-care. 
Given that adolescence poses a high-risk period for diabetes mismanagement, and 
consequently, threats to long-term health status, it is important to examine factors that 
contribute to individual differences in the propensity to exhibit poor DSM as well as 
engagement in other behaviors incompatible with good metabolic control such as 
substance use. As previously noted, the tendency of individuals to demonstrate poor 
DSM patterns during adolescence has been well documented (e.g., Hamilton & 
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Daneman, 2002; Jacobson et al., 1990; Johnson, 1995; Kovacs et al., 1992) and linked to 
biological and social changes that occur during puberty (i.e. growing levels of 
independence, increased importance of peer relationships, decreases in parental 
responsibility for management; Chase, 2002; Walker, 2002). However, it is also 
important to assess why some teenagers are more vulnerable than others to demonstrate 
poor management. Research has identified several dimensions of family functioning, 
environmental support, and cognitive styles to be correlated with self-management and 
metabolic control.  For example, low parental involvement (Grey et al., 2001), low 
perceived self-efficacy (Iannotti et al., 2006), health beliefs and attitudes (Patino, 
Sanchez, Eidson, & Delamater, 2005), high family conflict (Hauser et al., 1990), poor 
family communication (Miller-Johnson et al., 1994), and poor problem solving skills 
(Grey, Boland, Davidson, Li, & Tamborlane, 2000; Alioto & Janusz, 2004) have been 
shown to be related to decreased self-care and poorer metabolic control (See Appendix B 
for additional detail regarding psychosocial factors associated with metabolic control). 
However, one potentially important factor that has been absent from current 
conceptualizations is temperamental characteristics such as disinhibition. To explore the 
utility of this framework, the relationship between disinhibition and diabetes management 
was explored.  
Impact of Disinhibition on Diabetes Management 
Despite knowledge of adverse health consequences, youth with diabetes continue 
to engage in behaviors that negatively impact metabolic control and health status (albeit 
at a lower rate than non-diabetic children; Frey, Guthrie, Loveland-Cherry, Park, & 
Foster, 1997). As previously noted, adolescents are more likely to engage in poorer 
6  
  
behavioral adherence to diabetes regimen components (i.e., diet, exercise, insulin 
replacement; Jacobson et al., 1990) as well behaviors that are incompatible with good 
diabetes management, such as substance use (Rowe & Linver, 1996). Although rates of 
substance use among adolescents with diabetes appear to be somewhat lower than in the 
general population, there still exists a substantial prevalence. Studies have reported rates 
of 50% for alcohol use; 25% for drug use; and 50% for cigarette use among adolescents 
with diabetes (Glasgow, Tynan, & Schwartz, 1991; Gold & Gladstein, 1993) compared to 
community rates of 76.6% for alcohol use; 51% for drug use; and 54% for cigarette use 
(lifetime prevalence for 12th graders; Monitoring the Future Study [MTF], 2003). The 
incidence of substance use in this population is problematic because adolescents with 
diabetes are more vulnerable than others in their age group to the short and long-term 
effects of substances on physiological functioning. For example, smoking greatly 
increases morbidity and mortality (Ford & Newman, 1991; Gay, Cai, & Gale, 1992), and 
alcohol use increases the risk of hypoglycemia (American Diabetes Association [ADA], 
1998; Franz, 1990). In addition, use of tobacco, alcohol and other drugs has all been 
shown to be associated with poorer metabolic control (Glasgow et al., 1991; Lundman, 
Asplund, & Norberg, 1990). Clearly, a better understanding of an individual vulnerability 
to engage in behaviors that are incompatible with good diabetes management among 
adolescents is needed. This understanding might help to tailor and optimize the yield of 
approaches aimed at improving DSM and reducing the risk of health complications 
associated with diabetes (Biglan & Severson, 2003; Tucker, Ellickson, & Klein, 2003). 
Some have suggested that individual differences in cognitive/information 
processing, specifically risk perception, is an important factor in understanding decisions 
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to engage in health compromising behaviors among diabetic adolescents. The health 
belief model (HBM, Janz & Becker, 1984) is a conceptual framework that posits that 
perception of vulnerability to disease complications is a key factor in determining an 
individual’s health behaviors. In this framework, risk is defined as feelings of personal 
susceptibility or vulnerability to a condition where stronger feelings of vulnerability 
motivate behaviors aimed at reducing risk (Frey et al., 1997). A small number of studies 
(Frey et al., 1997; Joseph et al., 1992, 1994; Patino et al., 2006; Woolridge et al., 1992) 
have examined the role of risk perception in adolescents with diabetes on blood sugar 
levels and participation in risky behaviors. Generally, findings have not supported a 
significant association between perception of risk of complications and DSM or 
metabolic control. These findings are consistent with research in community samples of 
adolescents indicating that knowledge and perception of risks often does not correlate 
with behavior, and that accurately perceiving risk is not traditionally a sufficient or direct 
predictor of engagement in risky behavior (Sitkin & Weingart, 1995).  
In contrast, evidence has increasingly indicated that dispositional variables (i.e., 
personality and temperamental characteristics); specifically, differences across the 
disinhibition spectrum, may play a crucial part in engagement in risk behaviors among 
adolescents (Aklin, Lejuez, Zvolensky, Kahler, & Gwadz, 2005; Krueger et al., 2002; 
Lejuez, Aklin, Bornovalova, Moolchan, 2005; Sher, Bartholow, & Wood, 2000). 
Theoretical models suggest that disinhibition is a biologically based factor that may relate 
to risk taking specifically, as well as externalizing spectrum disorders more broadly 
(Markon, Krueger, & Watson, 2005). Determinants of trait-disinhibition have been found 
to be composed of several constructs, such as impulsivity and sensation seeking (Sher et 
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al., 2000; Zuckerman & Kuhlman, 2000). For the purposes of this study, we draw on 
Eysenck’s (1985) definition of impulsivity; namely, the tendency to enter into situations 
or rapidly respond to cues for potential reward without much planning or deliberation and 
without consideration of potential punishment. The most comprehensive definition of 
sensation seeking has been put forth by Zuckerman (1994), who defines it as “the seeking 
of varied, novel, complex, and intense sensations and experiences, and the willingness to 
take physical, social, legal, and financial risks for the sake of such experience 
(Zuckerman, 1994, p. 27).” Whereas impulsivity relates to the reduced ability to withhold 
approach behavior in the presence of reward-related stimuli (Brady, Myrick, & McElroy, 
1998), sensation seeking relates to sensitivity to reward stimuli, and consequently, the 
approach behavior in itself (e.g., Zuckerman, 1991; Zuckerman & Kuhlman, 2000). 
The construct of disinhibition as a broad characteristic has been proposed to 
underlie the propensity to engage in risky and norm-violating behaviors (i.e. substance 
use, risky sexual behavior, antisocial behavior) and is thought to have a biological, 
largely heritable basis.  Gray (1982) first theorized that neurological processes; 
specifically, the behavioral inhibition system (BIS) and behavioral activation system 
(BAS), influenced the tendency of individuals to engage in either anxious or impulsive 
behavior. The tendency of some individuals to persistently search for highly stimulating 
experiences has been linked to a low activation of the behavioral inhibition system, 
experienced as a relatively low level of anticipatory anxiety (e.g., Zuckerman, 1991). 
Indeed, research has linked self-reported BAS/BIS scores with frontal cortical activity 
(e.g., Hewig et al., 2006).  Similarly, others have noted that impulsivity and sensation 
seeking are indicators of a core neurobiological process; namely, the underlying 
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approach/avoidance system oriented toward engagement in hedonic behavior (Depue & 
Collins, 1999; Zuckerman, 1991; Zuckerman & Kuhlman, 2000). Others have rejected 
the theory that trait-personality variables form the primary basis for engagement in norm-
violating behaviors; rather, they propose that it is the interaction between 
personality/genetic predisposition and social-contextual variables that is of primary 
importance (e.g., Jaffee et al., 2005). Regardless of the etiological basis, studies have 
clearly documented a relationship between components of disinhibition (i.e. impulsivity, 
sensation seeking) and risky behaviors (i.e. substance use, smoking initiation, gambling, 
risky sexual behavior), as well as subsequent diagnosis of externalizing disorders 
(Krueger et al., 2002; Lejuez et al., 2002; Sher, Bartholow, & Wood, 2000; Tarter et al., 
2003; Zuckerman et al., 1988). 
Despite robust results that indicate a significant association between disinhibition 
and risky behavior, several aspects of extant research are in need of further improvement. 
For example, one limitation of research related to disinhibition in adolescents is the 
absence of comprehensive measures. Traditionally, researchers have relied exclusively on 
self-report instruments to determine levels of disinhibition, but these approaches have 
several limitations, and their success in identifying at-risk adolescents has been limited. 
In contrast, translational research and theory (Zvolensky, Lejuez, Stuart, & Curtin, 2001) 
have provided a strong argument for the assessment of disinhibition using on-line 
behavioral tasks. Based on these recommendations, researchers have developed the 
Balloon Analogue Risk Task (BART; Lejuez et al., 2002), which indexes manifest 
riskiness using a computer-generated behavioral task. This behavioral measure of risk 
taking propensity is easy-to-use and adolescent appropriate. In this task, larger prizes can 
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be earned for increased risk-taking up to a point at which overly risky behavior produces 
diminishing returns. Data suggest that level of risk taking propensity on the BART is 
related to current engagement in many real-world risk behaviors (e.g., smoking, 
delinquent behaviors), particularly those most relevant to risky behaviors in adolescents 
(e.g., unprotected sexual intercourse, polysubstance use). In addition, the BART has been 
shown to predict risk behaviors in adolescents over and above self-report assessments of 
impulsivity and sensation-seeking (Aklin et al., 2005; Lejuez, Aklin, Zvolensky, & 
Pedulla, 2003). Therefore, the use of behavioral tasks in addition to self-report 
instruments may provide a more comprehensive assessment of constructs related to 
disinhibition. 
A further limitation of extant research is that despite the association between 
behavioral and self-report assessments of constructs related to disinhibition and risk 
behaviors, this relationship has not yet been documented in samples of individuals with 
diabetes.  Similarly, there is a complete absence of research examining the relationship 
between disinhibition and the quality of diabetes self-management and metabolic control. 
Based on research on risk-taking behaviors in community samples of adolescents, it is 
clear that constructs related to disinhibition, measured by self-report instruments and 
behavioral tasks such as the BART, are correlated with a range of high-risk behaviors 
such as unsafe sexual practices, illicit drug use, alcohol use, and smoking, with all 
correlations ranging from .25 to .44 (e.g., Aklin et al., 2003; Lejuez et al., 2003). 
Therefore, adolescents with disinhibited personality styles are more likely to use alcohol 
and drugs. This phenomenon has particular relevance to adolescents with diabetes, given 
research to indicate that alcohol, tobacco and drugs have direct negative effects on 
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metabolic functioning. In addition, use of alcohol and drugs increases the propensity to 
make decisions oriented toward short, rather than long-term consequences (e.g., Bailey, 
Camlin, & Ennett, 1998; Hoffman, Klein, Eber, & Crosby, 2000; Stein et al., 2000). 
Thus, impaired judgment due to alcohol and drugs may also have indirect effects on 
metabolic control through less attention to self-management (which has long versus short 
term benefits).  
In addition to the relationship between disinhibition and substance use, 
adolescents in community samples who score higher on measures of disinhibition have 
been shown to be more likely to display norm-violating behavior and less consistent 
lifestyles (Sher & Trull, 1994). Therefore, one could presume that within a population of 
adolescents with diabetes, individuals with higher levels of disinhibition would be less 
likely to follow parental and physician recommendations regarding diabetes management, 
and to demonstrate an impaired ability to adhere consistently to regimen components 
(i.e., diet, exercise, insulin replacement).  
In sum, there is considerable reason to believe that adolescents who are more 
disinhibited are more likely to engage in substance use and to demonstrate more 
problematic self-management. Surprisingly, however, these hypotheses have yet to be 
subjected to empirical scrutiny. Given the adverse impact of poor self-management and 
substance use on metabolic functioning in adolescents with diabetes, it is important to 
examine whether personality variables such as disinhibition are associated with an 
increased vulnerability to engage in such behaviors. However, it is important to note that 
there are several limitations to pursuing such a line of research. First, similar to many risk 
assessment tools, many existing measures of diabetes self-management do not account 
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for the multidimensional nature of regimen components, do not account for different 
insulin delivery systems (e.g., pump), and do not correlate well with metabolic control. 
Recently, however, a structured interview for self-management behaviors has been 
developed (DSMP, Harris et al., 2000). This measure examines adherence across various 
regimen components and can be modified to account for recent advances in insulin 
therapy. In addition, unlike other measures, results correlate with metabolic control 
(Harris et al., 2000).  
In addition to limitations regarding measurement of self-management, blood 
glucose levels are also a fallible indicator of self-care behaviors. Much of the variance in 
metabolic control can be attributed to factors largely outside an individual’s control (e.g., 
genetic, biologic, demographic, characteristics of a patient’s individual regimen; 
Hamilton & Daneman, 2002). Therefore, a good measure of self-management may only 
account for a modest proportion of variance in diabetic control. However, similar to other 
chronic illnesses such as heart disease, behavioral factors such as exercise, diet, and 
engagement in high risk behaviors significantly contribute to health outcome and have 
implications for educational and treatment programs.  
Given the importance of understanding factors related to good metabolic control, 
the purpose of the current study was to examine whether disinhibition was related to 
metabolic control, and the extent to which self-management behavior and drug/alcohol 
use mediates this potential relationship. Results may have important implications for 
psychoeducational programs and treatment of uncontrolled diabetes in adolescents. For 
example, the current assumption that all teenagers need the same information presented 
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in the same fashion may not be warranted. Idiographic approaches that take into account 
level of disinhibition may be needed to address these individual differences. 
Chapter 2: Method 
Subjects 
 All subjects were recruited from diabetes clinics at Children’s National Medical 
Center (CNMC) and its satellite clinics located in the greater Washington DC 
metropolitan area. All children saw the same physician for their diabetes appointments. 
Inclusion criteria included adolescents (ages 13-18 years) with Type 1 diabetes, 
diagnosed for 6 months or more, and able to read and understand English. Subjects with 
an identified developmental disability (i.e. pervasive developmental disorder, Down’s 
syndrome) were excluded. Other identified psychiatric disorders were not excluded from 
the study. 
Procedure. 
Potential participants were identified from the CNMC log of diabetes clinic 
appointments. All individuals who met inclusion criteria (Type 1 diabetes, 13-18 years of 
age, diabetes diagnosis for at least 6 months, English speaking), had an appointment on a 
day the investigator was available, and who were not participating in other diabetes clinic 
studies were sent a letter which included a summary of study procedures (see Appendix 
C). Approximately 125 letters were sent to potential families. This letter was followed up 
by phone calls to potential study subjects inviting them to participate, following a brief 
screening to confirm eligibility and review of procedures. Two subjects were excluded 
based on phone screening, due to a PDD diagnosis and length of diagnosis less than 6 
months. Five potential subjects could not be called due to wrong/disconnected phone 
numbers. Upon phone contact, both the adolescent and a parent/legal guardian were 
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asked to participate on the date of their regularly scheduled clinic visit.  Individuals were 
informed that their participation was voluntary and would not affect treatment at any 
time. Administrative personnel at the participant’s clinic site were contacted prior to their 
scheduled visit, and a private room in which to conduct study procedures was reserved.  
Upon initial contact, study procedures were described simultaneously to both the 
parent and child. In the course of this description, it was emphasized that all study 
materials were confidential and therefore, parents would not have access to questionnaire 
responses. Parental consent and adolescent assent according to IRB requirements were 
obtained prior to conducting study-related procedures. Following an explanation of the 
study, the parent was directed to the waiting room to complete the demographic 
questionnaire, and adolescents completed study measures in a private room. Procedures 
were conducted either prior to or following their diabetes check-up appointment. 
Procedures took approximately 35-45 minutes. The order of administration of tasks 
(questionnaires, semi-structured interview, and computer task) was counterbalanced to 
minimize order effects. Questionnaires were self-administered and placed in envelopes 
labeled only with an ID number. The computer task (BART) was completed on a Dell 
Notebook computer with an attached mouse. The experimenter administering the BART 
was blind to participant responses on the self-report battery. Similarly, the experimenter 
administering the semi-structured interview was blind to participant responses on the 
BART and self-report measures. Given evidence that adolescents interviewed separately 
have statistically similar scores to adolescents who knew their parents were being 
interviewed (Harris et al., 2000), adolescents were interviewed alone to maximize truthful 
responding. All data were subsequently maintained in a locked file cabinet, with assent 
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forms maintained in a file separate from data to maintain confidentiality. Medical records 
were reviewed following their clinic visit to obtain A1c results. 
Measures. 
Four self-report questionnaires, one semi-structured interview, and one behavioral 




• Demographic Questionnaire. A brief questionnaire was used to collect data on 
age, gender, race, family income, education, duration of diagnosis, presence of 
diagnosed psychiatric disorders, and current insulin regimen. The caregiver who 




• Diabetes Knowledge Questionnaire (DKQ; Fitzgerald et al., 1998). The DKQ 
is a 23-item measure that assesses factual knowledge about diabetes. Fitzgerald et 
al. (1998) reported coefficient alphas ≥ 0.70 for the general test and the insulin-
use subscale in a sample of community and health department adult samples. On 
measures of validity, patients with Type 1 diabetes scored higher than patients 
with Type 2 diabetes, and patients who received diabetes education scored higher 
than patients who did not receive diabetes education. It was modified for this 
study to apply to adolescents.  The coefficient alpha for the current study was .73 
for the general test. 
 
Measures of Disinhibition 
 
• Zuckerman-Kuhlman Personality Questionnaire (ZKPQ; Zuckerman et al., 
1993). Impulsive sensation seeking (ImpSS) involves a lack of planning and the 
tendency to act impulsively without thinking. ImpSS was measured using the 
ZKPQ self-report questionnaire. The entire questionnaire consists of 99 questions 
and consists of five subscales that correspond to the Alternative Five Factor 
Model of Personality (Zuckerman et al., 1991). In the interest of time, only the 
ImpSS subscale, which consists of 19 forced choice items, was administered. 
These items do not assess specific activities; rather they describe a lack of 
planning and a general need for excitement and unpredictability. Zuckerman 
(2000) reported a 4-week test-retest coefficient alpha of .80 in a large sample of 
young adults. Internal reliability coefficients were good, ranging between .70-.80. 
The results of validity analyses indicated a high degree of convergence between 
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factors represented by the ZKPQ, NEO-PI-R, and EPQ-R, with loadings ranging 
from .72-.90. For the current study, the internal reliability coefficient for the test 
was good (α=.71).  
 
Behavior Analogue Risk Task (BART; Lejuez et al., 2002). This behavioral 
task has been successfully used to describe currently occurring risk behaviors in 
young adults (Lejuez et al., 2002) and adolescents (Aklin, Lejuez, Zvolensky, 
Kahler, & Gwadz, 2005; Lejuez, Aklin, Zvolensky, & Pedulla, 2003). The BART 
has demonstrated predictive value above and beyond that provided with 
demographics and self-report personality measures. In the first two preliminary 
studies on adolescents (Aklin, et al., 2005; Lejuez, et al., 2003), the BART was 
related to an aggregate of risk taking behaviors taken form the CDC Youth Risk 
Behavior Survey (r’s ranged from .30 to .50; all p’s < .05). Riskiness on the 
BART was related to illicit drug use in both studies and unsafe sexual practices in 
one of the studies. Therefore, preliminary data indicate that substance use is 
related to riskiness on the BART (r = .35). For the current study, reliability 
estimates were good. When broken down into the first, second and third sets of 10 
balloons, there was no significant difference between the number of pumps per set 
(p > .05). 
 
This task was administered on the computer. The computer screen displayed a 
small simulated balloon accompanied by a balloon pump, and a reset button 
labeled “Collect Points.” The left side of the screen showed a prize meter that was 
labeled, “small prize”, “middle prize”, “big prize” and “bonus”.  See Figure 1 for 
an illustration. Each pump of the balloon produced points that accumulated in a 
temporary bank. At any point during each balloon trial, the participant could stop 
pumping the balloon and click the “Collect Points” button. Clicking this button 
transferred all points from the temporary bank to the permanent bank and the 
prize meter bar was updated by incrementally increasing while a slot machine 
payoff sound effect played. If a balloon was pumped past its individual explosion 
point, an “explosion” sound effect was generated from the computer, all points in 
the temporary bank were lost, and the next uninflated balloon appeared on the 
screen. There were a total of 30 balloons (i.e., trials). These 30 balloons all had 
the same probability of exploding. Prior to task administration, subjects were 
seated in front of the computer screen, which displayed all task images. They 
were then read the following instructions: 
 
Throughout the task, you will be presented with a number of 
balloons, one at a time. You can click on the button labeled “Click 
this Button to Pump Up the Balloon” to increase the size of the 
balloon. Each click on the mouse pumps up the balloon a little 
more. You will receive points for each pump that will be kept in a 
temporary bank. At any point, you can stop pumping up the 
balloon and click on the button labeled "Collect Points." Clicking 
this button will start you on the next balloon and will transfer the 
money from your temporary bank to your permanent bank.  It is 
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your choice to determine how much to pump up the balloon, but be 
aware that at some point the balloon will explode. The explosion 
point varies across balloons, ranging from the first pump to 
enough pumps to make the balloon fill the entire computer screen. 
Each balloon can explode between 1 and 128 pumps, but the 
average balloon will pop at 64 pumps. If the balloon explodes 
before you click on “Collect Points”, then you move on to the next 
balloon and all the money in your temporary bank is lost. 
Exploded balloons do not affect the money in your permanent 
bank. In total there will be 30 balloons. The prize you get at the 
end will be determined by how high the prize meter is.  Any 
questions? 
 
Subjects were then shown a bulleted summary of these instructions on the 
computer screen. They were then directed to press the “ready to begin” button to 
start the program. At this time, the experimenter left the room. Each click on the 
pump inflated the balloon one degree (about .125” in all directions). The 
probability that a balloon would explode is arranged by constructing an array of N 
numbers. The number “1” was designated as indicating a balloon explosion. With 
each pump of the balloon, a number was selected without replacement from the 
array. The balloon exploded if the number 1 was selected. For this experiment, N 
equaled 128. Thus, the probability that the balloon would explode on the first 
pump was 1/128. If the balloon did not explode after the first pump, the 
probability that the balloon would explode was then 1/127 on the second pump, 
1/126 on the third pump and so on up until the 128th pump at which the 
probability of an explosion was be 1/1 (i.e., 100%). According to this algorithm, 
the average breakpoint was 64 pumps. Modeling real-world situations in which 
excessive risk often produces diminishing returns and increasing threats to one’s 
health and safety, each successive pump on any particular balloon trial (a) 
increased the amount to be lost due to an explosion and, (b) decreased the relative 
gain of any additional pump. 
 
Upon completion of 30 balloon trials, the computer program closed automatically, 
and resulting data stored by an ID number. The position of the prize meter was 
supposed to determine the final prize. In order to treat participants in the most 
equivalent way possible, all subjects were provided with their choice of either one 
$10 Blockbuster certificate or one $10 Target certificate. The intent of this design 
was to maximize level of effort on the task with an equitable distribution of prizes 




• Drug Use Diagnostic Identification Test (DUDIT; Babor & Del Boca, 1992). 
A quantity/frequency measure of all drugs (including nicotine) and alcohol was 
assessed with a standard self-report questionnaire adapted from the Alcohol Use 
Diagnostic Identification Test (e.g., Babor & Del Boca, 1992). Specifically, 
18  
  
participants responded to questions regarding use of a particular drug in their 
lifetime, use of it in the past 30 days, and frequency of drug use during the period 
of their life when they were using it most. Development of a composite score was 
guided by the work of Kirischi et al. (2002), who recommends adding the number 
of drug classes used (lifetime use) as a useful index of substance use involvement. 





• Glycosylated Hemoglobin Test (HbA1C). Glycemic control was assessed using 
the HbA1C, which is a widely accepted measure of average blood glucose levels 
over the prior 2-3 months (Wysocki et al., 2003). It is generally recommended 
that patients with diabetes have a quarterly HbA1C test in order to document the 
degree of glycemic control (ADA, 2004). Studies indicate that complication risks 
increase linearly with HbA1C levels (DCCT, 1994; See Figure 2). Typically, an 
HbA1C of <7% is recommended to avoid the risk of myocardial infarction and 
neuropathy (ADA, 2004). Blood draws were conducted as part of the child’s 
regular clinic visit following standard protocol and safety guidelines.  
 
• Diabetes Self-Management Profile (DSMP; Harris et al., 2000). The DSMP is 
a 23 item semi-structured interview that was designed to assess self-management 
behaviors over the previous 3 months in youths 11 years or older. The interview 
assessed behaviors across 5 domains: exercise, hypoglycemia management, diet, 
blood glucose testing, and insulin administration/dose adjustment. Higher total 
scores indicate better self-management. The interview may be administered to 
parents, children or parent-child dyads. Given evidence that adolescents 
interviewed separately have statistically similar scores to adolescents who knew 
their parents were being interviewed (Harris et al., 2000), adolescents were 
interviewed alone to maximize truthful responding. The total score has 
demonstrated adequate internal consistency (Cronbach’s α = .76), and test-retest 
reliability (3 month Pearson correlation, r = .67). In addition, unlike other 
measures, DSMP total scores have correlated significantly with HbA1C (r = -.28). 
The interview was administered by the experimenter, and began with a statement 
indicating that imperfect diabetes self-management is common and that few 
patients consistently do all that is asked of them. Unlike other measures of self-
care, questions could be adapted to accommodate various insulin delivery 
methods such as basal-bolus therapy and injection therapy. Twenty percent of the 
interviews in the current study were coded by a trained research assistant in order 
to assess inter-rater agreement. Although a kappa could not be computed, inter-
rater correlations were good with Pearson r’s above .80 for the total score and 
related subscales. In addition, the measure of internal consistency for the measure 
as a whole was good (α=.74). However, the alpha coefficients for individual 
subscales were less than .70, which is consistent with results obtained by the 
Harris et al (2000) study. Thus, individual subscales may be unreliable when 





Chapter 3: Results 
Sample Characteristics 
Forty-four subjects with Type I diabetes participated in this study. One subject 
was excluded because she had Type II diabetes, leaving 43 valid subjects. The average 
age of the subjects who participated was 15 years (SD = 1.5). Subjects had an average 
duration of illness of 6 years, 6 months (SD = 4.3). Approximately two-thirds were 
Caucasian (65%) with African-Americans representing the second largest racial group 
(20%), followed by Latinos (9.3%), and Native-American/Bi-racial children (4%). A 
little over half of the sample was male (56%). Of those who reported their income, 
approximately one-third came from households with a yearly income of $100,000 or 
more, approximately 28% with a yearly income between $40,000-100,000, and 10% with 
a yearly income less than $40,000 per year. A small percentage of the total sample were 
diagnosed with a psychiatric disorder, most commonly depression (7%), ADHD (7%), 
and anxiety (2%).  Approximately 6% of children who had any psychiatric diagnosis had 
at least one co-morbid diagnosis. Subjects were on a variety of insulin regimens with 
approximately 45% of participants on conventional injection therapy (2-3 shots per day), 
30% on basal-bolus therapy, and 23% on an insulin pump.  
Descriptive Statistics  
 
To examine relationships between primary variables of interest and 
demographics, and identify potential confounding variables, descriptive statistical 
analyses were conducted for the primary measures included in the current study. 
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Control Variable and Demographics 
The average total score on the diabetes knowledge questionnaire (DKQ) was 17.5 
(SD = 2.9). The DKQ correlated significantly with race and insulin regimen type 
although it did not significantly correlate with gender, age, income, parental education, 
age at initial diagnosis, or duration of illness. In general, teens who were on more 
sophisticated insulin delivery systems (i.e. basal/bolus and insulin pump versus 
conventional injections) demonstrated greater diabetes knowledge (M basal/pump = 16.1, 
M conventional = 18.5; F(1, 42) = 9.1, p < .01). In addition, white teenagers were much 
more likely to be on basal-bolus or insulin pump systems than were non-white teens (χ2 = 
22.5, p < .01) and to score higher on diabetes knowledge than nonwhites (M whites = 
18.1, SD = 2.6; M nonwhites = 16.3, SD = 2.9; F(1, 42) = 3.8, p = .05). White teenagers 
in the sample were also more likely to come from families with higher yearly incomes 
[F(1, 35) = 5.6, p < .05], although not education levels [F(1,40) = .87, p = ns]. Lastly, 
males in the current sample were significantly more likely to be white than non-white 
(white males n = 18, nonwhite males n = 6; χ2 = 3.2, p = .05). There were no differences 
between white and non-whites with respect to age or duration of illness.   
Metabolic Control   
As previously noted, hemoglobin A1c is a measure of average BG levels over the 
previous 3 months, with lower numbers correlating with lower BG levels and better 
metabolic control. The average A1c for the sample as a whole was 8.3% (SD = 1.1).  As 
illustrated in Figure 3, there was one significant outlier, with one subject having a 
significantly higher A1c than the rest of the sample (12.5%) that resulted in a negatively 
skewed distribution (skewness = 1.1). When this individual’s data was removed from 
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analyses, the data more closely approximated a normal distribution (skewness = .24, 
range = 5.9% - 10.3%). However, this individual’s data was included in subsequent 
analyses, as it did not produce a significant difference in results, unless otherwise noted. 
When averaged over the 3 time periods (6 and 3 months prior to the study date) the 
average A1c was largely equivalent to the day of the evaluation (M = 8.5%, SD = 1.2) 
and repeated measures analyses indicated no significant effect of time period (p > .05). 
Therefore, the A1c on the day of the evaluation was used in subsequent analyses of 
metabolic control.  
Metabolic control, as measured by A1c, was not significantly associated with age, 
length of diagnosis, parental education, parental income, diabetes knowledge, or the 
presence of psychiatric diagnoses. Importantly, however, metabolic control was strongly 
associated with race, with white teenagers in this sample having lower A1c levels than 
non-whites (M whites = 7.9, SD = .90; M non-whites= 9.1, SD = 1.3; F(1, 42) = 12.3,  p < 
.01, η2 = .23). In addition, metabolic control was significantly associated with gender, 
with boys being more likely to have lower A1c levels (M males = 7.9, SD = .88; M 
females = 8.8, SD = 1.3; F(1, 42) = 6.9, p = .01, η2 = .15). As would be expected, 
metabolic control was also significantly correlated with insulin regimen in that teens who 
were on the insulin pump and basal-bolus therapy had lower A1c levels than teens who 
were on conventional injection therapy (M conventional = 8.8, SD = 1.3, M basal/pump = 
7.9, SD = .86; F(1, 42) = 7.3,  p = .01, η2  = .15). See Tables 2 and 3 for correlation 
matrix and tests of significance.  
Given that A1c was related to race, insulin regimen, and gender, linear regression 
analyses were conducted with these as independent variables. The model as a total 
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accounted for approximately 32% of the variance in A1c level (R2 = .32). Results 
indicated that race predicted A1c level even when controlling for the effects of gender 
and insulin (sr2 = .34, p < .05). On the other hand, the relationship between A1c and 
gender was no longer significant after the other two variables were controlled for (sr2 = 
.05, p = ns), which is likely due to the fact that race was related to gender, with boys in 
this sample more likely to be white. Similarly, the relationship between A1c and insulin 
regimen was no longer significant after controlling for the other two variables (sr2 = .08, 
p = ns), which is likely due to the fact that whites were more likely to be on more 
sophisticated insulin delivery systems.  
Measures of Disinhibition 
Following the procedures outlined in Lejuez, 2002, instead of using an absolute 
average number of pumps on the BART, we decided a priori to use only adjusted values 
for all analyses. These adjusted values, defined as the average number of pumps 
excluding balloons that exploded (i.e., the average number of pumps on each balloon 
prior to prize collection), were preferable because the number of pumps was necessarily 
constrained on balloons that exploded, thereby limiting between subjects variability in the 
absolute averages. In addition, other potential dependent variables, such as number of 
explosions and unadjusted number of pumps, did not produce a different pattern of 
results. As noted in Table 4, the average adjusted number of total pumps for the sample 
as a whole was 40.66 (SD = 15.5). As illustrated in Figure 4, there were no significant 
outliers in terms of the total number of pumps on the BART made by individual subjects.  
The BART was not significantly correlated with age, diabetes knowledge as 
measured by the DKQ, parental income, age at initial diagnosis, psychiatric diagnoses or 
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parental education. However, it was significantly negatively associated with gender, with 
males making a higher number of pumps than females (M males = 46.2, SD = 14.3; M 
females = 35.1, SD = 14.0; F(1, 42) = 6.5, p = .01, η2 = .14). Similarly, the BART was 
significantly associated with race with whites making a higher number of pumps than 
non-whites (M whites = 46.0, SD = 12.9; M nonwhites = 32.6, SD = 14.3; F(1, 42) = 9.1, 
p < .01, η2  = .18). The number of pumps on the BART was also significantly associated 
with the teen’s type of insulin regimen with adolescents using the pump and basal bolus 
insulin replacement making a higher number of total pumps than those on conventional 
injection therapy (M conventional = 32.8, SD = 12.7; M  basal/pump = 48.1, SD = 13.3;  
F(1, 42) = 14.5, p < .01, η2 = .26).  
Given that BART was related to these other variables, linear regression analyses 
were conducted with gender, race, and insulin regimen as independent variables. The 
model as a total accounted for approximately 35% of the variance in number of average 
pumps made (R2 = .35). Results indicated that neither gender nor race was significantly 
related after controlling for the other two variables. However, insulin regimen was 
associated with the BART after controlling for gender and race, (sr2 = .43, p < .05, partial 
r = .35).  
Contrary to expectations, the total score on the self-report measure of impulsive-
sensation seeking (IMPSS scale) did not significantly correlate with the total (adjusted 
average) number of pumps on the BART (r = .086, p = ns). It also did not significantly 
correlate with age, race, gender, age at diagnosis, insulin regimen, parental income or 
education, or diabetes knowledge as measured by the Diabetes Knowledge Questionnaire 
(refer to Table 5 for correlation coefficients, all ps > .05). When the IMPSS scale was 
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broken down into component subscales; (impulsivity and sensation seeking) the 
equivalent pattern of results was found for each. 
Measures of Self Management  
As previously noted, the DSMP measures the degree to which individuals have 
managed various components of their diabetes regimen over the previous three months. It 
has a range between 0-79, with higher scores reflective of better management. The mean 
total score on the self-management questionnaire in the current sample was 52.83 (SD = 
10.3). Twenty-five percent of the DSMP interviews were audiotaped for inter-rater 
reliability analyses. However, due to poor sound quality, 23% of the interviews were 
ultimately coded. Results indicated high inter-rater agreement for the total management 
score (r = .94).  
The total score on the DSMP did not significantly correlate with gender, age, 
presence of psychiatric diagnoses, or highest degree obtained. It did correlate 
significantly with race (r = .40, p = .01), and insulin regimen (r = .39, p < .05). In the 
current sample, white teenagers reported a higher degree of self-management on the 
DSMP than nonwhite teenagers (M whites = 56.4, SD = 8.4; M nonwhites = 46.3, SD = 
10.5; F(1, 41) = 11.7, p < .01, η2 = .23) and teens who were on conventional injection 
therapy demonstrated management to a lower extent (F(1, 42) = 12.8, p < .01, η2 = .24). 
In addition, the correlation between the total score on the DSMP and diabetes knowledge 
approached significance (r = .27, p = .08) in that the teens who scored better on the 




As shown in Table 9, approximately two-thirds of the sample (65%) reported that 
they had never used tobacco, alcohol, illegal drugs or abused prescription drugs. 
Approximately 28% reported that they had used between one to three different classes of 
substances in their lifetime; primarily tobacco (14%), alcohol (23%), and inhalants 
(11%). Due to the relatively low frequency of drug use, the total number of drugs used 
over the child’s lifetime was used as a proxy for engagement in substance use. The mean 
number of types of drugs used for the sample was 0.8 (SD = 1.32) with a range between 0 
and 5. Drug use did not significantly correlate with gender, age, race, parental income, or 
length of diagnosis (all ps > .05). There was also no significant relationship between drug 
use and self-management behaviors as reported on the DSMP. However, the correlation 
between drug use and diabetes knowledge approached significance (r = -.27, p = .07), in 
that teens who scored better on the diabetes knowledge questionnaire had a tendency to 
report less drug use. Due to low frequency of drug use, the relationships were further 
explored by splitting subjects into two groups; those who had never used drugs (n = 28) 
and those who had ever used drugs (n = 15). There was no difference in any of the 
relationships between drug use and variables of interest, including gender, race, age, self-
management behaviors, or diabetes knowledge.  
Tests of Hypotheses 
Hypothesis 1. Subjects who demonstrate greater levels of disinhibition (measured by 
self-report and BART) will have poorer glycemic control (HbA1C) after controlling 
for diabetes knowledge. 
 
The self report measure of impulsivity/sensation seeking was not correlated with 
the behavioral measure of risk taking. Therefore, the two measures could not be 
combined into a single disinhibition construct as proposed, and analyses for each are 
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conducted separately. In addition, diabetes knowledge was not significantly correlated 
with HbA1c. Therefore, gender, race and insulin regimen, which were significantly 
correlated with the primary outcome measure, were included as control variables instead 
of diabetes knowledge.  Results of partial coefficient analyses indicated that self-reported 
ratings of disinhibition were not significantly correlated with HbA1c (r = .09, p = ns) 
after controlling for gender, race, and insulin regimen.  Similarly, the total number of 
average pumps on the behavioral measure of disinhibition (BART) was not significantly 
correlated with HbA1c (r = -.12, p = ns) after controlling for gender, race, and insulin 
regimen. This profile of results did not change when using the average A1c over the three 
time periods, when removing the subject who presented the A1c outlier from the analysis, 
or when breaking the self-report measure into its component subscales. When the 
variability of A1c levels over three time periods were examined (to explore whether any 
changes in A1c levels were related to disinhibition), there continued to be no association 
between the self report measure (r= -.06, p = ns) or the behavioral measure (r= .22, p = 
ns). 
Hypothesis 2. Subjects who demonstrate greater levels of disinhibition (measured by 
self-report and BART) will be more likely to engage in a pattern of behavior that is 
detrimental to their health across the following domains: a) substance use and b) 
poor engagement in self-management behaviors directly related to diabetes care 
(measured by the DSMP) after controlling for diabetes knowledge. 
 
Again, as the self report measure of impulsivity/sensation seeking was not 
correlated with the BART, partial correlation analyses are conducted separately for each 
measure. In addition, as substance use and self-management were not correlated with 
diabetes knowledge, control variables included gender, race, and insulin regimen.  
Results indicated that the total (adjusted average) number of pumps on the BART did not 
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significantly correlate with use of drugs either when examined continuously (total drug 
classes used; r = .17, p = ns), or when the drug use variable was divided into two groups: 
no use and any use of drugs (r = .07, p = ns).  
The number of pumps on the BART did not correlate with self-management total 
score (r = .23, p = ns). In contrast, the self-report measure of impulsive-sensation seeking 
did significantly correlate with drug use after controlling for race, gender, and insulin 
delivery type (r = .44, p < .01), with teens who reported higher levels of disinhibited 
behavior engaging in drug use to a higher degree.  However, it did not correlate with the 
self-management total score (r = -.02, p = ns). The measure continued to not correlate 
with the DSMP when subscales (impulsivity and sensation seeking) were analyzed 
separately.  
Hypothesis 3. The pattern of self-care behaviors in Hypothesis 2 will be related to 
poorer glycemic control (HbA1C) after controlling for diabetes knowledge and 
controlling for disinhibition. 
 
HbA1c was not significantly correlated with use of drugs (r = -.001, p = ns) or the 
total score on the self-management questionnaire (r = -.15, p = ns) after controlling for 
race, gender, type of insulin regimen, and disinhibition measures. 
Hypothesis 4. The relationship between disinhibition and glycemic control will be 
close to zero when controlling for self-management behaviors described in 
Hypothesis 2. 
 
Due to the lack of the correlation between measures of disinhibition, variables 
were analyzed separately. Results of partial correlation analyses indicated that there was 
no significant relationship between disinhibition and glycemic control after controlling 
for self-management behaviors (ps > .05).  





The findings of preliminary analyses indicated that race was significantly 
associated with several key variables including diabetes health knowledge, type of insulin 
regimen the teens were placed on, diabetes self-management, and the measure of 
metabolic control (A1c). Specifically, white teens scored higher on diabetes knowledge 
than non-whites, were more likely to be placed on more complex insulin delivery 
systems, and were significantly more likely to have lower A1c levels and demonstrate 
more engagement in diabetes self-management. The fact that children who scored higher 
on diabetes knowledge, were more adherent to regimen components, and had better 
metabolic control were more likely to use basal-bolus/pump therapy is perhaps not 
surprising, given that knowledge and behavioral adherence are frequently prerequisites 
for determining this transition. But why would white adolescents be presenting with 
lower A1c levels and better diabetes specific knowledge? Results indicated that neither 
diabetes knowledge nor self-management correlated significantly with metabolic control 
and did not mediate this association to a substantial degree. The fact that diabetes 
knowledge in and of itself did not significantly associate with metabolic control is 
consistent with previous research. While there is clearly a minimum threshold of 
knowledge required to manage the disease, it is not a sufficient predictor of metabolic 
control.  This phenomenon is particularly salient during adolescence where longitudinal 
studies indicate deteriorating behavioral adherence over the course of adolescence despite 
increases in diabetes-related health knowledge (Du Pasquier-Fediaevsky, Chwalow, & 
Tubiana-Rufi, 2005). Similarly, much of the variance in metabolic control can be 
attributed to factors largely outside an individual’s control (e.g., genetic, biologic, 
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demographic, characteristics of a patient’s individual regimen; Johnson, 1998) and thus 
may not necessarily correlate with self-management behaviors 
In contrast, the insulin delivery method accounted for a significant proportion of 
variance in the relationship between race and metabolic control, suggesting that this 
variable is an important factor in mediating this association. However, the causal 
direction of association is unclear. The more sophisticated delivery systems, such as the 
insulin pump, are designed to more closely mimic normal pancreatic functioning (e.g., 
Castellanos, 2005). On the other hand, children who have better metabolic control to 
begin with and who demonstrate responsible behavioral adherence are also more likely to 
be placed on these systems by their physicians. Thus, more research is needed to 
disentangle this relationship. 
It is possible that socio-economic factors associated with race may be potential 
mediators of the relationship between race and metabolic control. Although whites and 
non-whites in the current sample were statistically equally likely to fall in the middle 
income groups ($40-80 thousand yearly income) and to have similar educational 
backgrounds, white teens in this sample were far more likely to be in families with 
incomes over $100,000 per year, and less likely to be in families with yearly incomes less 
than $40 thousand (χ2=8.3, p < .05). However, the relationship between race and 
metabolic control was present even when the effect of income and education was 
controlled for.  
Thus, it is unclear why white adolescents in the current sample presented with 
greater health knowledge and also improved metabolic control. There has been relatively 
little research examining ethnic minority populations with Type 1 diabetes. However, 
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results on effects of race in the current study are consistent with emerging research in this 
area that indicate that minority youth are more likely to exhibit poorer glycemic control 
and recurrent episodes of DKA (Auslander, Thompson, Dreitzer, White, & Santiago, 
1997; Delamater et al., 1999). One study indicated that black youth are more likely to 
have poorer glycemic control even after controlling for insulin dosage, diabetes duration, 
and socioeconomic status (Delamater, Albrecht, Postellon, & Gutai, 1991). Fewer studies 
have examined the course of type 1 diabetes with other ethnic minority groups. One study 
in the U.S. found that in comparison to Latino youth, black youths were at highest risk of 
poor metabolic control even when there were no significant differences with respect to 
insulin dosage, body mass index (BMI), or Tanner pubertal stage (odds ratios indicated 
that blacks were 3.9 more likely than whites and 2.5 times more likely than Hispanics to 
be classified as being in poor glycemic control; Delameter, et al., 1999). Similarly, 
another study of seventy-four minority adolescents indicated that regimen adherence 
problem and poor glycemic control were higher in black youth relative to Hispanic youth 
(Patino et al., 2005). In a study conducted from a national register of children in 
Denmark, results indicated that ethnic minorities of any type were more likely to have 
worse glycemic control compared to their Danish counterparts (Povlsen, Olsen, & 
Ladelund, 2005). 
Health care disparities for minority youths, especially those of lower SES, have 
been well documented (e.g., Airhihenbuwa, 2006). Children from racial and ethnic 
minorities encounter more health problems and impact disproportionately on the health 
care system (Furino & Munoz, 1991; U.S. Dept of Health & Human Services, 1991) In 
examining mechanisms that may underlie this phenomenon, Naar-King et al (2006) 
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suggests that in addition to individual factors (i.e. mental health symptoms) and family 
factors (i.e. parental involvement) that have been commonly linked to poor outcomes for 
children with Type 1 diabetes, the social-ecological theory posited by Bronfenbrenner 
(1979) may be a useful framework in which to understand illness management. Using this 
framework, minority youth may be more likely to experience worse metabolic control as 
they are more likely to have inadequate access to health care, less support in school 
systems, and more likely to have public health insurance (Delamater, 1999). Furthermore, 
there are often language barriers, cultural differences in health beliefs, higher parental 
stress, and lower education levels that may all impact an adolescent’s ability to manage 
their diabetes. Thus, although the reasons are unclear, we do observe the same pattern 
here as in other studies, suggesting that some relationship between race and diabetes 
management exists. It is likely that an unknown third variable, possibly related to family 
or cognitive factors (i.e. self-efficacy or health beliefs) that have been shown to be related 
to outcome, are associated with race and may accounts for the differences observed here. 
It would be interesting for future research to collect such information so that the 
mechanism underlying this relationship can be better explored. 
Self-management 
The mean total score on the self-management questionnaire (DSMP) in the 
current sample was 52.83. This is consistent with research that shows more reduced 
treatment compliance as children reach adolescence. In our sample, there was no 
significant difference in behavioral adherence by younger or older cohorts. Again, race 
and insulin regimen were significant factors in determining the extent to which 
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adolescents adhered to their regimen, with whites and those not on conventional insulin 
therapy reporting more consistent participation in self-management.  
In the current study, there was a trend for diabetes knowledge to be associated 
with behavioral adherence as measured by the DSMP; however, this relationship did not 
reach the level of statistical significance. Although it is possible that a larger sample size 
may have been able to detect a significant difference, other studies have indicated that 
deteriorating behavioral adherence over the course of adolescence occurs despite 
increases in diabetes-related health knowledge (e.g., Dumont et al., 1995; Du Pasquier-
Fediaevsky, Chwalow, & Tubiana-Rufi, 2005).  Thus, diabetes knowledge appears to be 
more important in younger samples, but not necessarily to older adolescents, who are 
more likely to engage in risk behaviors despite knowledge of consequences.  
Somewhat surprisingly, the total score on the DSMP did not significantly 
correlate with metabolic control. Although much of the variance in metabolic control can 
be attributed to factors largely outside an individual’s control (e.g., genetic, biologic, 
demographic, characteristics of a patient’s individual regimen; Johnson, 1998), and a 
good measure of self-management may only account for a modest proportion of variance 
in diabetic control, previous studies examining psychometric properties of the DSMP 
have yielded significant correlations between the DSMP total score and A1c level (Harris 
et al., 2000; Lewin et al., 2005). The lack of association may relate to differences in 
sample characteristics as these previous studies had larger sample sizes (n > 100) and 
slightly younger children on average. In addition, similar to previous studies, the five 
subscales on the DSMP demonstrated poor internal consistency, with all alphas below 
.70. This is consistent with a recent psychometric study of the DSMP (Lewin et al., 2005) 
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in which confirmatory factor analysis of the rationally derived five subscales yielded poor 
fit indexes and subsequent exploratory factor analysis supported a two-factor solution for 
both the parent and adolescent adherence ratings, one relating to food and insulin 
schedule adherence (FISA) and the other related to adherence to blood sugar testing and 
adjustments (ABST). To further explore the utility of this framework, the 2-factor model 
was analyzed in the current study. Results supported increased internal consistency with 
these two factors (FISA factor alpha = .70, and the ABST factor alpha = .68). However, 
the associations between these factors and measures of disinhibition and metabolic 
control remained nonsignificant. It would be interesting for future research to examine 
the association between these subscales and metabolic control to explore whether specific 
subscales can more consistently predict A1c levels.  
Substance use reported by subjects in the current sample was somewhat less than 
that reported in other studies of adolescents. As previously noted, in an epidemiological 
study of substance use among teens in the 12th grade, approximately 76% reported 
alcohol use and 51% other drug use (Monitoring the Future Study [MTF], 2003). In the 
current sample, only 26% reported that they had used any substances in their lifetime; 
primarily tobacco (14%), alcohol (23%), and inhalants (11%). It is important to note, 
however, that this epidemiological research is based on samples of older teens (12th 
graders). However, the rate was still lower than that found in a sample of teens with 
diabetes among the same age range (Glasgow et al., 1991). It is possible that rates of drug 
use reported could reflect a social desirability effect, as all measures were completed in 
the doctor’s office environment. 
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Self-reported substance use in this study did not significantly correlate with 
gender, age, race, parental income, or length of diagnosis. There was a trend for those 
who were more knowledgeable about their conditions to use drugs to a lesser degree, 
which suggests that diabetes knowledge may be an important component in the decision 
to engage in substance use. However, the directionality cannot be attested for due to the 
cross-sectional study design. 
Disinhibition 
The average adjusted total number of pumps on the BART behavioral measure 
was used as a measure of disinhibition. The total pumps for the sample as a whole was 
40.66. Given that subjects were informed that the average balloon would explode at 64 
pumps, this indicates that on average, subjects responded more cautiously. The BART 
was significantly associated with gender and race, with males making a higher number of 
pumps than girls and whites making more pumps than non-whites. Previous research 
using the BART in adolescent samples (e.g., Aklin, 2005; Lejuez, 2003) has not yielded 
differences with respect to gender and it appears that the gender effect in the current 
study was primarily accounted for by the fact that males in the study were more likely to 
be white. In addition, it was unexpected that the self report measure of 
impulsivity/sensation seeking was not correlated with the BART. However, a recent 
study examining the reliability and validity of the BART for inner-city adolescent 
samples indicated that it did not correlate with self-reported impulsivity, but was 
associated with sensation seeking and real world risk behaviors (Lejuez et al., in press). 
In our sample, the sensation seeking subscale, when partialled out from the impulsivity 
subscale, also did not significantly associate with the BART. It is unclear why results are 
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discrepant from previous research. One potential reason is that the adolescents in the 
current sample were given information about the point at which the balloon would 
explode, which is a method that was not consistently used in other studies. It addition, 
previous research on adolescents using the BART have primarily focused on African-
American youth in an inner-city environment; and results may not generalize to the 
characteristics of the current sample. Finally, the size of the payout was a bit more 
modest than in previous studies with adolescents, using a range up to $25 in prizes.  
Tests of Hypotheses 
In general, data from the current sample did not support the study hypotheses. 
Results indicated that self-report and behavioral measures of disinhibition were not 
significantly correlated with metabolic control after controlling for gender, race, and 
insulin regimen. This finding suggests that individual factors related to disinhibition were 
not directly related to glycemic control. In examining the relationship between 
disinhibition and behavioral management, results were more inconsistent. As 
hypothesized, the self-report measure of impulsive-sensation seeking (IMPSS) did 
significantly correlate with substance use. However, the behavioral measure of risk 
propensity was not associated with engagement in risk behaviors such as substance use. 
This finding varies with the results of several other studies indicating that in adolescent 
populations, the BART is strongly related to engagement in real-world risk behaviors 
such as substance use and shows incremental predictive value above and beyond that 
provided by self-report measures (e.g., Aklin et al., 2003, 2005, Lejuez et al., 2005). 
Again, it is not clear why the BART did not correlate with substance use in the current 
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study, but it is possible that it is related to the relatively low use of substances, small 
sample size, and differences in demographic characteristics mentioned previously.  
In addition, although the IMPSS measure was correlated with substance use, it 
was not significantly correlated with diabetes self-management behaviors after 
controlling for gender, race and insulin type. Similarly, performance on the BART did 
not correlate with diabetes self-management. Contrary to our hypothesis, self-
management, as measured by the DSMP, was not correlated with either metabolic control 
or with substance use. The fact that the self-management did not correlate with glycemic 
control is not altogether surprising, as these two are inconsistently related in previous 
research due to confounding variables such as biological changes that occur in 
adolescence. In addition, there appears to be a more complex, bidirectional relationship 
between adherence and glycemic control (Fediavsky, 2005). 
Conclusions 
In sum, the results of the current study indicate that disinhibition is not directly 
related to behavioral adherence, engagement in health incompatible behaviors, or 
glycemic control. Rather, results suggest that sample characteristics, particularly race and 
insulin regimen, are the key variables in assessing overall management in adolescence. 
However, results of this study should be interpreted with caution as there were several 
limitations including a relatively small sample size, relatively limited drug use, and cross-
sectional design. In addition, like most studies, we used a retrospective account of 
management behaviors and relied on adolescent report. Twenty-four hour recall 
interviews, conducting a parent interview, or use of online systems may increase 
accuracy of reporting. Given the increased salience of risk-taking behaviors and non-
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adherent diabetes management in older adolescence (i.e. Iannotti et al., 2006), it is 
possible that effects of disinhibition may not be apparent until this time. Although there 
were no effects by age in the current study, there may not have been an adequate number 
of children or sufficient power to detect an effect. Furthermore, the current study utilized 
a normative sample of children presenting for clinic visits, which resulted in a limited 
range of A1c levels. It is possible that domains of disinhibition may be more salient for 
those on the extreme end of poor metabolic control (i.e. those who would likely be 
referred for behavioral services). Unfortunately, our data did not contain enough 
individuals from this end of the spectrum to conduct such analyses. However, it may be 
useful for future research to examine disinhibition in clinic referred samples, particularly 
those with ADHD, who demonstrate high levels of impulsive responding. 
Given that impulsivity relates to the reduced ability to withhold approach 
behavior in the presence of reward-related stimuli and that disinhibition diminishes the 
ability to consider consequences of behavior, it would be interesting to explore the impact 
of disinhibited personality styles on the management of chronic illnesses that have more 
immediate adverse consequences. Research supports the notion that generally, appraisal 
of short-term health risks play a more important role in determining behaviors than 
longer-term consequences (e.g., Patino, 2005). Often, the effects of high blood sugar are 
long-term in nature and serious effects such as kidney, vascular, and eye problems 
manifest after several years. Therefore, the lack of immediate consequences may be a 
central driving force, regardless of personality characteristics, for this type of condition. 
It would be interesting to see whether there is a stronger relationship between risk-
38  
  
propensity and self-management for illnesses where the effects of nonadherence are more 
immediate and certain, such as may occur for other conditions like epilepsy.  
The study also had a number of strengths, including adding to the literature an 
examination of individual temperamental characteristics and diabetes management. In 
addition, unlike other studies on diabetes management, we utilized a behavioral tool 
rather than relying on self-report alone. Furthermore, the demographic characteristics of 
the study sample, including race and gender, are similar to the characteristics of 
adolescents seen through CNMC diabetes clinics. Overall, current estimates indicate that 
the population of outpatients seen in the CNMC diabetes clinics are composed of 
approximately 50% female, 30% African American, 2% Hispanic, and 1% Asian/ Native 
American/ Pacific Islander. In the current sample, there were slightly fewer females 
(44%) and African-American children (22%) and slightly more Hispanic children (10%) 
represented. Thus, the current sample appears to be generally representative of 
adolescents seen through the CNMC diabetes clinics.  
In general, the current study illustrates the need for research to examine the 
complexity of diabetes management in adolescence. Specifically, longitudinal studies are 
needed to examine the course of management behaviors and assist clinicians with 
predicting individuals at greatest risk of demonstrating health management problems. By 
identifying those who are vulnerable, prevention efforts and intervention programs can be 
best directed toward this population. In addition, the different pattern of correlations 
obtained between the behavioral (BART) and self-report measure of impulsivity (IMPSS) 
with engagement in risky health behaviors suggest that these two measures are tapping 
into unique variance across a range of risk behaviors and highlights the need to include 
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both in future research. Most striking is the finding that race was an important component 
of many of the key variables, which highlights the importance of social-ecological factors 
that may outweigh individual factors. The increased morbidity documented in adult 
blacks with diabetes (e.g., Tull, Makame, & Roseman, 1994) may begin during this age 
period. Unfortunately, this finding is consistent with other research in pediatric 
psychology and medicine that document marked disparities for ethnic minorities and 
disadvantaged populations in the current health care system (e.g., Airhihenbuwa, 2006). 
It is important for future research to examine the effects of dispositional and social-
ecological factors in determining health behaviors for youth with diabetes so that policy, 
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Demographic Characteristics of the Study Sample 
Variable Frequencies (Total N = 43) 
 
Age (years) M = 15.1, SD = 1.5 
Gender  
      Male 24 
     Female 19 
Race  
       White 28 (65.1%) 
  Black 9 (20.9%) 
  Latino 4 (9.3%) 
  Native American 1 (2.3%) 
  Bi-racial 1 (2.3%) 
Average Household Incomea 
(per year, in thousands) 
 
 $20-39 5 (10.2%) 
 $40-69 6 (12.2%) 
 $70-99 8 (16.3%) 
 $100 or more 16 (32.7%) 
Insulin Regimen  
 2 injections/day 5 (11.6%) 
 3 injections/day 14 (32.6%) 
 Basal/bolus 13 (30.2%) 
 Pump 10 (23.3%) 
Age at Diagnosis (years)b M = 8.3 years, SD = 4.1 
Duration of Illness (years)b M = 6.6 years, SD = 4.3 
Psychiatric Diagnosesc  
 ADHD 2 (4.1%) 
 Depression 3 (6.1%) 
 Anxiety 1 (2.0%) 
 More than one dx 3 (6.1%) 
 None 31 (63.3%) 
Psychiatric medication  
 Stimulant 2 (4.1%) 
 Mood stabilizer 2 (4.1%) 
 Antidepressant & 
 stimulant 
1 (2.0%) 
 None 32 (65.3%) 
Note.  a Five subjects did not report income level. b Four subjects did not report age at 




























Tests of Significance for Hemoglobin A1c and Demographic variables 
 Mean SD Test Statistic Measure of 
Association 
(η2) 
Total Sample 8.3  1.1   
Gender   F(1,42)= 6.9, p=.01 .15 
 Males (n=24) 7.9 .88   
  Females (n=19) 8.8 1.3   
Race   F(1,42)=12.3, p<.01 .23 
 Whites (n=28) 7.9 .84   
 Non-Whites (n=15) 9.1 1.3   
Insulin Regimen     
 Conventional (n=19)  8.8  1.3 F(1,42) = 7.3, p=.01 .15 
 Basal/pump (n=23)  7.9  .86   
 
  
Table 3  
 

















A1c day of eval  __ -.265 -.152 .260 -.538** .381* -.496** .080 -.088 -.125 
DK total # correct   __ .247 .050 .378* .102 .472** .106 .251 .067 
Age    __ -.098 -.049 .036 .088 .149 .037 .157 
Agedxa     __ -.179 .281 -.299 -.180 .092 -.077 
Race      __ -.339* .578** .166 .554** .224 
Gender       __ -.133 .255 .052 -.085 
Insulin regimen        __ .171 .429* .307 
Highest degree         __ .597** .066 
Yearly incomeb          __ .302 















Note.  * Correlation is significant at the 0.05 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed). 








BART Descriptive Statistics 
 Mean SD 
 
Total # pumps – adjusted average 40.7 15.5 
# of pumps 1st set of 10 (adjusted ave) 43.2 19.2 
# pumps – 2nd set of 10 (adjusted ave) 39.7 17.5 

























Pearson r Intercorrelations Between Measures of Disinhibition and Demographics 
Variable # pumps - 
adj ave total 
DK- total # 
correct 




 Income Psyc dx 
# pumps - 
adj ave 
total 
__ .284 -.027 -.235 .484** -.371* .385* -.038 .197 .126 
IMPSS .086 -.226 -.189 -.013 .148 -.079 -.138 .258 .084 -.179 
DK- total  
# correct 
 __ .247 .050 .378 .102 .472** .106 .251 .067 
Age   __ -.098 -.049 .036 .088 .149 .037 .157 
Age Dxa    __ -.179 .281 -.299 -.180 .092 -.077 
Race     __ -.339 .578** .166 .554** .224 
Gender      __ -.133 .255 .052 -.085 
Insulin 
regimen 
      __ .171 .429* .307 
Highest 
degree 
       __ .597** .066 
Yearlyb 
income 
        __ .302 
Psyc dxc          __ 
Note.  ** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
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Tests of significance for BART by demographics 
 Mean SD Test Statistic Measure of 
Association 
(η2) 
Gender   F(1,42)= 6.5, p=.01 .14 
 Males (n=24) 46.2 14.3   
  Females (n=19) 35.1 14.0   
Race   F(1,42) = 9.1, p < .01 .18 
 Whites (n=28) 46.0 12.9   
 Non-Whites (n=14) 32.6 14.3   
Insulin Regimen   F(1,42) = 14.5, p < .01 .26 
 Conventional (n=19) 32.8 12.7   






Intercorrelations Between Measures of Self-Management and Demographics 
MP DS           
Total #  







Total DK- total 
# correct







Total # drugs __ .101 .196 -.036 -.182 -.014 -.015 -.275 -.019 -.109 .087 .041 -.298 -.314 -.013 .000 
Exercise  __ .231 .196 .389 -.383 .441 .263 -.088 .030 .147 .085 .195 .175 .234 .124 
Hypogly 
Cemia 
  __ .203 .247 .249 .462 -.060 -.085 -.284 .146 .139 .083 .120 .035 .290 
Nutrition    __ .377 .375 .872 .292 .149 -.229 .427** -.333* .483** .253 -.032 .296 
Glucose 
checks 
    __ .099 .658 .206 -.085 -.156 .367* -.275 .258 .265 .019 .120 
Insulin       __ .460 -.047 .244 -.214 -.067 -.314* -.138 -.066 -.278 -.054 
DSMP total       __ .271 .092 -.260 .400** -.306 .385* .277 -.012 .282 
DK - total # 
correct 
       __ .247 .102 .378 .050 .472 .043 .106 .251 
Age         __ .036 -.049 -.098 .088 .130 .149 .037 
Gender          __ -.339 .281 -.133 -.151 .255 .052 
Race           __ -.179 .578 .259 .166 .554 
Age dx            __ -.299 -.057 -.180 .092 
Insulin 
regimen 
            __ .251 .171 .429 
Psyc dx              __ .073 .324 
Highest  
Degree 
              __ 97
me __
 .5  
Inco                  
** Correlation is significant at the 0.01 level (2-tailed) 







Tests of Significance for Total Score on DSMP  
 Mean SD Test Statistic Measure of 
Association 
(η2) 
Race   F(1,41)= 11.7, p<.01 .23 
 Whites (n=28) 56.4  8.4    
 Non-Whites (n=14) 46.3 10.5   
Insulin Regimen   F(1,42)= 12.8, p<.01 .24 
 Conventional (n=19) 47.3 11.1   
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Frequency of Lifetime Substance use 




Tobacco 6 14 
Alcohol 10 23.3 
Marijuana 2 4.7 
Inhalants 5 11.6 
Cocaine 0 0 
MDMA 0 0 
Stimulants 0 0 
Hallucinogens 1 2.3 
Prescription Drugs   
 Tranquilizers 1 2.3 
 Sedatives 1 2.3 
 Opiates 0 0 
 Other 0 0 
   









Number of Drug Classes Used over Lifetime 
 # Classes of Drugs Frequency (n) Percent 
0 28 57.1 
1 6 12.2 
2 2 4.1 
3 5 10.2 
4 1 2.0 
5 1 2.0 






Appendix A.  Type 1 Diabetes: Medical Management 
Prior to the discovery of insulin in 1922, diabetes was a terminal illness. Without 
the ability to metabolize carbohydrates, individuals with diabetes would literally starve to 
death despite consumption of food. Upon the availability of insulin, diabetes changed 
from a fatal illness to a chronic disorder that could be medically managed (Johnson, 
1997). However, life expectancy for children diagnosed with diabetes remains only 75% 
of normal (Travis, Brouchard, & Shiner, 1987). 
Children with Type 1 diabetes depend on exogenous insulin to survive. There are 
a variety of insulin types available that vary by absorption rate, peak action, and duration. 
They can be prescribed alone or in combination with other types, and are available in 
concentrations of 100 or 500 units/ml (ADA, 2004). Conventional treatment involves 
subcutaneous insulin injections with a syringe or pen-like device 2 or 3 times per day. For 
this type of treatment, intermediate-acting insulin (i.e. NPH, Lente) is commonly 
prescribed in combination with short-acting insulin (Regular) in order to minimize peaks 
in BG levels (Davidson, 1991). Injection sites can include the tissue of the upper arm, 
thigh, buttocks, and abdomen, with variable rates of absorption from each site. Rotation 
of the injection site is important to prevent hypertrophy (ADA, 2004). The disadvantage 
of this type of treatment is that it does not permit rapid changes in insulin availability in 
response to increases or decreases in BG levels (Johnson, 1998). Thus, the patient must 
adhere to a diet of specified carbohydrates and regimented mealtimes. In addition, 
because NPH insulin action peaks 6-10 hours after administration with activity 
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diminishing after that time, there is a greater risk of hypoglycemia in the early morning 
hours, and normal BG levels are harder to maintain (Chase, 2002).   
In addition to the convention injection treatment described above, another method 
of insulin replacement is known as basal-bolus therapy. This treatment involves one daily 
injection of a long-acting (background) insulin (i.e. Lantus®) combined with pulses 
(boluses) of rapid acting insulin (i.e. NovoLog, Humalog). The advantage of this therapy 
is that Lantus has no pronounced peaks and a nearly 24-hour duration of action (Chase, 
2002). The rapid acting insulin, which peaks between 30-60 minutes, can be taken prior 
to meals to cover extra carbohydrate intake and to correct high BG levels. Therefore, 
there is increased dietary flexibility and improved metabolic control. The disadvantage of 
this treatment is that individuals are required to engage in more frequent injections and 
BG checks, and count carbohydrates. Therefore, individuals on basal-bolus therapy must 
demonstrate increased attention to diabetes self-care (Wang, Carabino, & Vergara, 2003).  
Recently, the insulin pump, or continuous subcutaneous insulin infusion (CSII), 
has been offered as an alternative to multiple daily injections (Hanas, 2001). The pump is 
a microcomputer that allows insulin to be delivered continuously (through 
preprogrammed basal infusion rates) to mimic normal physiological functioning. 
Additional intermittent insulin doses (bolus) must be given at meal and snack times, and 
to correct abnormal glucose levels (Chase, 2002; Kaufman, Halvorson, Fisher & 
Pitukcheewanot, 1999). Individuals using the insulin pump also are required to engage in 
intensive BG monitoring, record keeping, and carbohydrate counting. In addition, 
patients must make daily complex decisions, and understand mathematical concepts 
related to insulin corrections and carbohydrate to insulin ratios. Due to the complexity of 
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this regimen, it is often recommended that patients demonstrate the appropriate 
motivation, skills and cognitive maturity prior to being placed on the pump (ADA, 1998). 
In addition, there is an increased risk of weight gain and hypoglycemia, particularly if 
patient management is inadequate (Tamborlane & Ahern, 1997). However, the pump has 
significant advantages over conventional therapy including less variability in insulin 
absorption, better matching of insulin to food intake, marked dietary flexibility and better 
control of BG levels (Leichter, Reynolds, & Bolick, 1985; Wredling, Hannerz & 
Johansson, 1997). 
 However, it is important to note that all insulin replacement systems only 
approximate normal pancreatic function. Therefore, both hyperglycemia and 
hypoglycemia can regularly occur and must be managed to avoid complications. Diabetes 
is associated with serious complications that typically occur 15-20 years after disease 
onset. For example, it is the primary case of new cases of blindness among those aged 20-
74 (Winer, 2004), accounts for approximately 25% of all new cases of end-stage renal 
disease (Daneman, 2006), and 40-45% of all non-trauma caused amputations in this 
country (Rayman, 2004).  Fortunately, the results of a large clinical trial have indicated 
that intensive management can decrease mean BG levels and prevent or slow the 
progression of many complications, including retinopathy, nephropathy (kidney disease) 
and neuropathy (nerve disease; DCCT, 1994). 
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Appendix B: Type 1 Diabetes: Psychological and Behavioral Considerations 
 Because there is no cure, diabetes management requires daily attention over the 
course of one’s lifespan. As Johnson (1998) notes, a disease that is characterized by both 
chronicity and complexity presents numerous behavioral challenges, particularly in 
adolescence. Clearly, appropriate medical management of diabetes is essential for 
survival. However, behavioral factors such as adherence to medical regimens, coping 
skills, and family systems also play an important role in maintaining good metabolic 
control. In addition, having a chronic illness such as diabetes may place children with this 
condition at increased risk for the development of psychological problems (Lavigne & 
Faier-Routman, 1992). Given the importance of behavioral and psychological factors to 
overall management, the purpose of the next section is to review psychological aspects of 
diabetes in children and adolescents. 
 Numerous studies have attempted to identify psychosocial factors that place 
children at risk for poor metabolic control. As previously noted, age is one of the key 
predictors of poor self-management, with adolescence representing the developmental 
period of least adherent behavior (e.g., Hamilton & Daneman, 2002). Demographic 
characteristics, including race and income, have been related to increased hospitalizations 
for DKA and poor metabolic control (Auslander et al., 1997; Cohen et al., 2002). Family 
factors have been widely studied, and several variables related to family functioning have 
been linked with regimen adherence and metabolic control. For example, there is 
increasing evidence that parental involvement is predictive of improved glycemic control 
(e.g., Anderson, Brackett, & Ho, 2000). During adolescence, it is developmentally 
appropriate for children to become more autonomous and self-sufficient. Thus, it is also a 
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time when parents start to withdraw their involvement in diabetes management. 
However, LaGreca and colleagues (1995) noted that adolescents who had greater 
responsibility for insulin administration were in poorer metabolic control and families 
who provided support for regimen tasks had adolescents who demonstrated better 
treatment adherence. In addition, family communication, problem solving skills, and 
conflict resolution skills are also correlated with treatment adherence and metabolic 
control in cross sectional studies (Hauser et al., 1990; Wysocki, 1993) and associated 
prospectively with outcomes in longitudinal studies (Hauser et al., 1990; Jacobson et al., 
1994).  
 In addition to support from family members, social support from peers is 
particularly important during adolescence. This increased significance can have 
potentially adverse or beneficial effects on adherence and metabolic control. For 
example, adolescents may demonstrate poor dietary adherence when with friends 
(Delamater et al., 1988), and succumb to peer pressure to experiment with drugs, tobacco, 
and nicotine (Walker, 2002). On the other hand, peers may provide positive emotional 
support with respect to diabetes care that may be reflected in better adherence. Although 
assessment of peer support has received limited attention, one controlled study reported 
benefits on adjustment and knowledge following a peer group intervention (Greco, 
Pendley, McDonell, & Reeves, 2001). 
Children with diabetes usually function normally in the classroom setting, and 
have IQ scores consistent with the general population (Johnson, 1998). However, 
diabetes is associated with neuropsychological effects that may interfere with diabetes 
management (Ryan & Williams, 1993). Although it is beyond the scope of this paper to 
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provide a comprehensive review of neuropsychological sequelae of diabetes, there is 
evidence that in some children, diabetes is associated with adverse acute and chronic 
cognitive effects, particularly in children diagnosed before the age of 5. For example, 
Type 1 Diabetes is associated with poorer performance on selective neurocognitive tasks, 
including tasks that tap visual-motor, memory, and attentional skills (see Rovet, 2000; 
Ryan & Williams, 1993, for reviews). Although no consistent pattern of 
neuropsychological findings has emerged, it is important to note that children with 
diabetes may be more likely to display selective executive functioning deficits that may 
adversely impact diabetes management (Wysocki, Greco, & Buckloh, 2003). Such 
findings highlight the importance of studying the impact of variables related to executive 
functioning (i.e. impulsivity) on self-management behaviors and metabolic control. 
There is also increasing evidence that children with diabetes are at increased risk 
for psychological problems such as depression, anxiety, and eating disorders compared to 
the general population. For example, Kovacs et al. (1997) indicated that 27% of diabetic 
youths in their sample had an episode of major depressive disorder (MDD) and 13% had 
a diagnosable anxiety disorder during the 10 years after the onset of diabetes. This rate 
compares with 20% for MDD and 8% for anxiety disorders in community samples 
(lifetime prevalence prior to the age of 18; Lewinsohn et al., 1993). The incidence of 
psychopathology in this population is problematic because disorders such as depression 
and anxiety have been linked with poorer glycemic control (Grey, Cameron, & Thurber, 
1991; Lustman et al., 1996). Interestingly, however, other studies have linked 
internalizing problems such as depression and negative attributional cognitive styles with 
better glycemic control (Cohen et al., 2004; Brown et al., 2001). 
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In addition, adolescents with diabetes (particularly adolescent girls) may be at 
higher risk for the development of eating disorders (Wysocki et al., 2003) and is 
associated with worse metabolic control. It is estimated that as many as 31% of female 
adolescents and adults purposefully omit insulin (to avoid weight gain associated with 
insulin treatment or to compensate for binge-eating; Polonsky et al., 1994; Takii et al., 
1999) and 10% meet diagnostic criteria for an eating disorder, a rate which is twice as 
high as in girls without diabetes (Jones et al., 2000; Rydall et al., 1997). 
In general, child psychopathology and behavior problems have been associated 
with poorer adherence and metabolic control (Liss et al., 1998). Kovacs et al (1995) 
identified risk factors for multiple hospitalization related to diabetes in school-aged 
children and found that higher levels of externalizing behavior problems, younger age at 
diagnosis, and low SES were significant predictors of admissions. Although longitudinal 
studies are needed to examine the nature of this association, there is likely a bidirectional 
relationship between diabetes and behavior problems. This research highlights the 
importance of assessing psychological problems and family functioning in working with 
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